When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NovoCure (NVCR) reported strong Q2 results, beating both revenue and EPS estimates. Part of the beat was a non-recurring $5 million revenue benefit, but Optune has delivered strong sequential and Y/Y growth even if the one-time benefit is excluded. NovoCure saw good news on all fronts in the last few months – approval for Optune in mesothelioma (though it’s called NovoTTF-100L™ specifically for mesothelioma, I will use Optune in the article because of the familiarity and it’s basically the same device), Medicare reimbursement for newly diagnosed GBM and now, a strong quarter for